Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of BCR-ABL1 transcript as a result of reciprocal translocation between chromosome 9 and 22. The most common transcripts subtypes are e13a2 (b2a2) and e14a2 (b3a2). The prognostic impact of the type of BCR-A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Genthon, Alexis, Nicolini, Franck Emmanuel, Huguet, Françoise, Colin-Gil, Carole, Berger, Marc, Saugues, Sandrine, Janel, Alexandre, Hayette, Sandrine, Cohny-Makhoul, Pascale, Cadoux, Nadine, Cayuela, Jean-Michel, Campos, Lydia, Guyotat, Denis, Flandrin-Gresta, Pascale
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335668/
https://ncbi.nlm.nih.gov/pubmed/32655840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27652
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars